apolipoprotein A-IV (Research Corp Technologies)

N/A

Report date: 2025/03/17 20:00:36
NME

Base Information

Drug Nameapolipoprotein A-IV (Research Corp Technologies)
Drug Alias NameAPO A-IV (Research Corp Technologies)apolipoprotein A-IVhuman apolipoprotein A-IV
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApolipoproteins modulators
TargetsApolipoproteins
Therapy Area/IndicationsFeeding and Eating Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued
Highest Status in ChinaN/A
Originator CompaniesResearch Corporation Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesResearch Corporation Technologies
Active IndicationsN/A
Inactive IndicationsFeeding and Eating Disorders

Other Information

ATC CodeN/A
Related LinksN/A